Spleen Stiffness

2

Review clinical trials related to Spleen Stiffness. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

The Value of Spleen Stiffness Measurement in Patients With PBC

Recent evidence suggests that combining liver stiffness measurement (LSM) with spleen stiffness measurement (SSM) significantly improves risk stratification in patients with PBC. In a study the addition of spleen stiffness to liver stiffness enhanced the prediction of liver decompensation, providing a more precise evaluation of portal hypertension. Furthermore, when combined with platelet count, this approach effectively identified patients with a low probability of harboring HRVs. This could allow clinicians to safely avoid unnecessary endoscopic procedures in selected patients, improving patient comfort and reducing healthcare costs. Therefore, our patients participating in this trial will undergo follow up (every 6 months) as per Standard of care. This includes a blood draw, FibroScan and Ultrasound. Together with this, 2 questionnaires will be completed (not as per SOC) and during the FibroScan, a spleen stiffness measurement will be performed.

Participants needed: 125
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Universitair Ziekenhuis BrusselUpdated: May 1, 2026Locations: 1
Eligibility criteria

≥18y [+3]

<18y [+1]

Status: Recruiting

Effect of Malnutrition on Liver and Spleen Stiffness in Children

This prospective observational study aims to evaluate the effect of malnutrition on liver and spleen stiffness in children using shear wave elastography. Two groups of participants will be enrolled: children diagnosed with malnutrition and age-matched healthy controls. Organ stiffness measurements will be compared between the two groups to assess the impact of malnutrition on liver and spleen tissue properties.

Participants needed: 300
Trial details
Age: 1-18Biological sex: AllType: ObservationalSponsor: Mehmet Akif AĞIRUpdated: Apr 17, 2025Locations: 1
Eligibility criteria

Children aged 6 to 18 years. [+2]

Children with chronic diseases (e.g., liver disease, diabetes, immunocompromised... [+2]